We are live on ! Find out more
TCM

Tamarack Capital Management Portfolio holdings

AUM $840M
1-Year Est. Return 19.47%
This Fund
S&P 500
This Quarter Est. Return
+17%
1 Year Est. Return
+19.47%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$422M
AUM Growth
+$44.6M
Cap. Flow
+$2.83M
Cap. Flow %
0.67%
Top 10 Hldgs %
69.03%
Holding
44
New
12
Increased
9
Reduced
7
Closed
15

Top Buys

Rank Stock Value
1
VOLC
VOLCANO CORPORATION COM STK
VOLC
+$14M
2
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
+$13.7M
3
WELL icon
Welltower
WELL
+$9.81M
4
INSY
Insys Therapeutics, Inc.
INSY
+$9.78M
5
NXTM
NxStage Medical Inc.
NXTM
+$9.73M

Top Sells

Rank Stock Value
1
DGX icon
Quest Diagnostics
DGX
+$23.2M
2
PCRX icon
Pacira BioSciences
PCRX
+$15.8M
3
VPHM
VIROPHARMA INC
VPHM
+$13.7M
4
MDAS
MEDASSETS INC COM STK (DE)
MDAS
+$11.2M
5
NTUS
Natus Medical Inc
NTUS
+$8.35M

Sector Composition

Rank Sector Weight
1 Healthcare 43.34%
2 Real Estate 4.02%
3 Technology 2.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$92.3M 21.87%
500,000
-100,000
-17% -$17.7M
IWM icon
2
PUT
iShares Russell 2000 ETF
IWM
$80.9B
$34.6M 8.2%
+300,000
New +$33.1M
ALKS icon
3
Alkermes
ALKS
$8.82B
$28.1M 6.64%
690,000
+65,000
+10% +$2.4M
AUXL
4
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
$25.9M 6.14%
1,250,000
+725,000
+138% +$13.7M
VOLC
5
DELISTED
VOLCANO CORPORATION COM STK
VOLC
$25.7M 6.08%
1,175,000
+630,950
+116% +$14M
SPNC
6
DELISTED
Spectranetics Corp
SPNC
$19.3M 4.56%
770,300
+40,300
+6% +$864K
CFN
7
DELISTED
CAREFUSION CORPORATION
CFN
$18.3M 4.34%
460,000
+235,000
+104% +$9.14M
ITGR icon
8
Integer Holdings
ITGR
$3.35B
$17.7M 4.19%
438,800
-10,970
-2% -$386K
ATRC icon
9
AtriCure
ATRC
$1.77B
$15.7M 3.72%
841,600
-58,400
-6% -$849K
AGN
10
CALL
DELISTED
Allergan Inc
AGN
$13.9M 3.29%
125,000
– –
COV
11
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$12.9M 3.06%
190,000
+25,000
+15% +$1.63M
VAR
12
DELISTED
Varian Medical Systems, Inc.
VAR
$12.8M 3.04%
188,163
+45,615
+32% +$3.04M
VCRA
13
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$11.7M 2.77%
750,000
+325,000
+76% +$5.55M
DXCM icon
14
DexCom
DXCM
$27.6B
$11M 2.6%
1,240,000
-67,176
-5% -$532K
MDXG icon
15
MiMedx Group
MDXG
$626M
$10.5M 2.48%
+1,200,000
New +$7.35M
INSY
16
DELISTED
Insys Therapeutics, Inc.
INSY
$9.1M 2.15%
+705,000
New +$9.78M
WELL icon
17
Welltower
WELL
$178B
$8.84M 2.09%
+165,000
New +$9.81M
NXTM
18
DELISTED
NxStage Medical Inc.
NXTM
$8.82M 2.09%
882,000
+857,000
+3,428% +$9.73M
BMR
19
DELISTED
BIOMED REALTY TRUST INC
BMR
$8.15M 1.93%
+450,000
New +$8.53M
SRGA
20
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$6.11M 1.45%
57,549
-15,784
-22% -$1.53M
STRM
21
DELISTED
Streamline Health Solutions
STRM
$5.54M 1.31%
+52,959
New +$5.82M
OXFD
22
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$5.33M 1.26%
+275,000
New +$4.86M
CTRX
23
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
$4.75M 1.12%
+100,000
New +$4.72M
PCRX icon
24
Pacira BioSciences
PCRX
$1.02B
$4.31M 1.02%
75,000
-300,000
-80% -$15.8M
LMNX
25
DELISTED
Luminex Corp
LMNX
$3.86M 0.92%
+199,200
New +$3.77M
1
2

Similar funds

RI
Relational Investors San Diego, California $840M AUM 0.57% 1-Year Est. Return
CWA
Constellation Wealth Advisors New York $903M AUM 2.38% 1-Year Est. Return
GHF
Good Harbor Financial Barrington, Illinois $916M AUM 5.96% 1-Year Est. Return
F
FutureAdvisor San Francisco, California $617M AUM 6.57% 1-Year Est. Return
TRV
Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return
BMCMI
Bryn Mawr Capital Management Inc Bryn Mawr, Pennsylvania $577M AUM 6.5% 1-Year Est. Return
GACM
Green Arrow Capital Management New York $535M AUM 14.21% 1-Year Est. Return
AH
Achievement Holdings Chicago, Illinois $1.2B AUM 9.2% 1-Year Est. Return

Tamarack Capital Management's Q4 2013 Portfolio in Review

As of Q4 2013, Tamarack Capital Management held 44 positions worth $422M, up 12% from $378M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Tamarack Capital Management's Q4 2013 filing shows 12 new, 9 increased, 7 reduced and 15 closed positions. Its largest new stake was Welltower: 165,000 shares worth $8.84M. The largest sale was Quest Diagnostics, an estimated $23.2M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 46% a quarter earlier, followed by Real Estate and Technology.

  • Tamarack Capital Management's largest Q4 2013 buy was Welltower: 165,000 shares worth $8.84M.
  • Tamarack Capital Management added most to VOLCANO CORPORATION COM STK in Q4 2013, an estimated $14M increase.
  • Tamarack Capital Management's biggest Q4 2013 reduction was Pacira BioSciences, cutting an estimated $15.8M.
  • Tamarack Capital Management fully exited Quest Diagnostics in Q4 2013, selling an estimated $23.2M.
  • Tamarack Capital Management's ten largest holdings make up 69% of its $422M portfolio in Q4 2013.
  • Tamarack Capital Management opened 12 new positions and closed 15 in Q4 2013.
  • Tamarack Capital Management's portfolio value rose 12% quarter-over-quarter to $422M.

Based on Tamarack Capital Management's 13F filing for Q4 2013, filed 13 Feb 2014.